4.4(top 10%)
impact factor
665(top 20%)
papers
15.6K(top 10%)
citations
57(top 10%)
h-index
4.6(top 10%)
impact factor
793
all documents
17.9K
doc citations
100(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Inflammation as a central mechanism in Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions20181,254
2Alzheimer's disease drug development pipeline: 2019Alzheimer's and Dementia: Translational Research and Clinical Interventions2019546
3Alzheimer's disease drug development pipeline: 2018Alzheimer's and Dementia: Translational Research and Clinical Interventions2018469
4Alzheimer's disease drug development pipeline: 2020Alzheimer's and Dementia: Translational Research and Clinical Interventions2020353
5Alzheimer's disease drug development pipeline: 2017Alzheimer's and Dementia: Translational Research and Clinical Interventions2017331
6Drug discovery and development: Role of basic biological researchAlzheimer's and Dementia: Translational Research and Clinical Interventions2017330
7Marked gender differences in progression of mild cognitive impairment over 8 yearsAlzheimer's and Dementia: Translational Research and Clinical Interventions2015274
8Alzheimer's disease drug development pipeline: 2022Alzheimer's and Dementia: Translational Research and Clinical Interventions2022271
9Alzheimer's disease drug development pipeline: 2021Alzheimer's and Dementia: Translational Research and Clinical Interventions2021259
10White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunitiesAlzheimer's and Dementia: Translational Research and Clinical Interventions2019250
11Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigmsAlzheimer's and Dementia: Translational Research and Clinical Interventions2017240
12Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions2018199
13Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trialsAlzheimer's and Dementia: Translational Research and Clinical Interventions2019165
14The roles of inflammation and immune mechanisms in Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions2016161
15Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic reviewAlzheimer's and Dementia: Translational Research and Clinical Interventions2019161
16Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5Alzheimer's and Dementia: Translational Research and Clinical Interventions2017160
17Racial and ethnic differences in trends in dementia prevalence and risk factors in the United StatesAlzheimer's and Dementia: Translational Research and Clinical Interventions2018154
18Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trialAlzheimer's and Dementia: Translational Research and Clinical Interventions2015137
19Speed of processing training results in lower risk of dementiaAlzheimer's and Dementia: Translational Research and Clinical Interventions2017114
20First‐in‐human, double‐blind, placebo‐controlled, single‐dose escalation study of aducanumab (BIIB037) in mild‐to‐moderate Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions2016113
21Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain healthAlzheimer's and Dementia: Translational Research and Clinical Interventions2017111
22The Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal‐dominant Alzheimer's disease, including a placebo‐treated noncarrier cohortAlzheimer's and Dementia: Translational Research and Clinical Interventions2018107
23Social interaction and cognitive decline: Results of a 7‐year community interventionAlzheimer's and Dementia: Translational Research and Clinical Interventions2017105
24UB‐311, a novel UBITh® amyloid β peptide vaccine for mild Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions2017104
25Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trialsAlzheimer's and Dementia: Translational Research and Clinical Interventions2018104
26Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b studyAlzheimer's and Dementia: Translational Research and Clinical Interventions2017102
27The ALFA project: A research platform to identify early pathophysiological features of Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions201697
28The effects of noncoding aquaporin‐4 single‐nucleotide polymorphisms on cognition and functional progression of Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions201794
29Predicting mild cognitive impairment from spontaneous spoken utterancesAlzheimer's and Dementia: Translational Research and Clinical Interventions201794
30Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug developmentAlzheimer's and Dementia: Translational Research and Clinical Interventions201794
31Lower brain and blood nutrient status in Alzheimer's disease: Results from meta‐analysesAlzheimer's and Dementia: Translational Research and Clinical Interventions201792
32Web‐enabled conversational interactions as a method to improve cognitive functions: Results of a 6‐week randomized controlled trialAlzheimer's and Dementia: Translational Research and Clinical Interventions201587
33Alzheimer's drug‐development pipeline: 2016Alzheimer's and Dementia: Translational Research and Clinical Interventions201687
34Measuring cognition and function in the preclinical stage of Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions201887
35A randomized, double‐blind, placebo‐controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot studyAlzheimer's and Dementia: Translational Research and Clinical Interventions201883
36Is late‐onset Alzheimer's disease really a disease of midlife?Alzheimer's and Dementia: Translational Research and Clinical Interventions201582
37Racial disparities and temporal trends in dementia misdiagnosis risk in the United StatesAlzheimer's and Dementia: Translational Research and Clinical Interventions201981
38The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions201980
39Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions201979
40A systematic review of the use of virtual reality and its effects on cognition in individuals with neurocognitive disordersAlzheimer's and Dementia: Translational Research and Clinical Interventions201979
41A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: Results from the Aging and Cognitive Health Evaluation in Elders Pilot StudyAlzheimer's and Dementia: Translational Research and Clinical Interventions201776
42Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trialAlzheimer's and Dementia: Translational Research and Clinical Interventions201875
43Electrical brain stimulation in different variants of primary progressive aphasia: A randomized clinical trialAlzheimer's and Dementia: Translational Research and Clinical Interventions201875
44A phase 1 clinical trial of the sigma‐2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions201973
45African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trialsAlzheimer's and Dementia: Translational Research and Clinical Interventions201771
46Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims dataAlzheimer's and Dementia: Translational Research and Clinical Interventions201971
47Inferior parietal transcranial direct current stimulation with training improves cognition in anomic Alzheimer's disease and frontotemporal dementiaAlzheimer's and Dementia: Translational Research and Clinical Interventions201770
48A randomized, single ascending dose study of intravenous BIIB092 in healthy participantsAlzheimer's and Dementia: Translational Research and Clinical Interventions201870
49A metabolite‐based machine learning approach to diagnose Alzheimer‐type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortAlzheimer's and Dementia: Translational Research and Clinical Interventions201970
50Phase II clinical trials of anti–amyloid β antibodies: When is enough, enough?Alzheimer's and Dementia: Translational Research and Clinical Interventions201769